Skip to main content

Correction: Saliva as a non‑invasive specimen for COPD assessment

The Original Article was published on 29 January 2022

Correction:  Respiratory Research (2022) 23:16 https://doi.org/10.1186/s12931-022-01935-9

Following the publication of the original article [1], it was noted that the Supplementary file 2 has been processed incorrectly.

The correct Additional file 2—supplementary methods been updated and included in this correction.

The original article has been corrected.

Reference

  1. Melo-Dias S, Valente C, Andrade L, Marques A, Sousa A. Saliva as a non-invasive specimen for COPD assessment. Respir Res. 2022;23:16. https://doi.org/10.1186/s12931-022-01935-9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ana Sousa.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Additional file 2.

Supplementary Methods. Supplementary table S2. Summary of clinical parameters distribution across Clusters I and II. Comparisons between clusters were conducted with Mann-Whitney U-test and chi-square test. Supplementary table S3. Summary table of significant logistic regression models established for both GOLD D and hospital admission, adjusted for Pack-years. Coefficients were represented in model equations. Supplementary figure S1. Salivary bacteria composition is different between patients with COPD and healthy controls. A) Bar-plot representing the differentially abundant genera between moderate patients with COPD and healthy controls inferred by LEfSe at a significance cut-off of 3. B) Bar-plot representing the differentially abundant genera between moderate patients with COPD and healthy controls inferred by LEfSe at a significance cut-off of 3. C) Bar-plot representing the differentially abundant genera between severe patients with COPD and healthy controls inferred by LEfSe at a significance cut-off of 3. A), B) and C) the differential OTUs inferred by ANCOM at 0.7 significance cut-off are represented in underlined. Supplementary figure S2. Salivary bacteria composition is different between the two clusters. Bar-plot representing the differentially abundant genera between cluster 1 and cluster 2 inferred by LEfSe at a significance cut-off of 3. The differential OTUs inferred by ANCOM are represented in underlined at 0.7 signofciance cut-off.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Melo‑Dias, S., Valente, C., Andrade, L. et al. Correction: Saliva as a non‑invasive specimen for COPD assessment. Respir Res 23, 370 (2022). https://doi.org/10.1186/s12931-022-02249-6

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/s12931-022-02249-6